The UK BioIndustry Association (BIA) and data and insights company Clarivate have released their annual UK Biotech Financing report – and, on the whole, the findings are not positive. While ...

Previously served as CEO and Founder of Mariana Oncology until its acquisition by Novartis in 2024 and CSO of Ra Pharma until its acquisition by UCB in 2020 NEW YORK and WALTHAM, Mass., May 22, 2025 ...

Philadelphia, Pennsylvania Saturday, May 24, 2025, 14:30 Hrs [IST] ...

The UK biotech company is putting its huge failure in allergy treatment behind it with a new deal with AstraZeneca (AZ). But British venture capital leader David Grainger is highly critical of the ...

President Trump on Thursday claimed his recent “most favored nation” executive order could cause U.S. drug prices to “drop like a rock” in just a matter of weeks, saying the savings will be ...

Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...

The Dementia Discovery Fund ("DDF"), managed by SV Health Investors, today announced the final closing of its second fund, DDF-2, with $269m in commitments. DDF is the world's largest family of ...

biotech, medcomms, diagnostics, AI, digital health and beauty tech businesses at the campus. The science and innovation campus by Bruntwood SciTech - the UK’s largest property platform dedicated to ...

The Trump administration shared the outlines of how it plans to push drug companies to lower their prices in the U.S.

Ventures Tour featuring a range of portfolio pitch sessions hosted by some of Cambridge’s most prominent venture capital ...

From using infants gut bacteria to protect adults from cancer, to growing rice on the ocean's surface and non-browning bananas - Norwich ...